Morgan Stanley analyst Gaurav Rateria reiterated a Buy rating on Makemytrip yesterday and set a price target of $118.00. The company’s shares closed yesterday at $92.34.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Rateria is a 4-star analyst with an average return of 20.9% and a 55.56% success rate.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Makemytrip with a $119.17 average price target, a 29.06% upside from current levels. In a report released on September 28, Goldman Sachs also reiterated a Buy rating on the stock with a $123.00 price target.
MMYT market cap is currently $8.95B and has a P/E ratio of 106.18.
Based on the recent corporate insider activity of 11 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MMYT in relation to earlier this year.
Read More on MMYT:
Disclaimer & DisclosureReport an Issue
- Strategic Leadership Changes at MakeMyTrip Drive Buy Rating
- MakeMyTrip Announces Strategic Leadership Changes
- MakeMyTrip Approves All Resolutions at Annual Shareholders’ Meeting
- Positive Outlook for MakeMyTrip: Strong Revenue Growth and Market Positioning Amid Challenges
- MakeMyTrip: Strong Market Position and Growth Potential Justify Buy Rating
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
